Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA TAD 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA TAD 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Tad Pharma Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 951b0b3384b7191d
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA TAD 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85195
Holder Company Name: Tad Pharma Gmbh
Marketing Company Name: Krka Farmaceutica S.L.
Holder Company Detail Path: /organization/tad-pharma-gmbh
Authorization Date: 2020-06-25
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/10 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Tad Pharma Gmbh
Company Detail Path: /organization/tad-pharma-gmbh

OLMESARTAN MEDOXOMILO

40 mg

AMLODIPINO BESILATO

13,88 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 25, 2020

Approval ID

951b0b3384b7191d

Type

Standard